Life Science Venture Creation & Investments

Corporate Development Services

Extera Partners is building new life science companies leveraging unique deal flow, team of industry leaders, own financing resources and a close network of family offices and institutional investors. Since its inception in 2007 as a corporate development advisory firm, the Extera team generated substantial financial returns to investors through strategic transactions and public listings

Our
Team

Extera’s team has been working together for over a decade. Our team’s collective experience exceeds one hundred and fifty years of corporate development and management experience in the biotechnology and medical device sectors.

Venture Creation

Creation, acceleration and management of new biotechnology and medical device ventures that seek to improve clinical outcomes, enhance quality of life and reduce healthcare costs.

Transaction

Facilitation of strategic transactions including mergers, structured acquisitions, research and development collaborations, technology and product licensing, global distribution transactions and capital investments.

Private Placement

Undisclosed

Acquisition

$83,000,000

Collaboration

$500,000,000

Collaboration

$350,000,000

Private Placement

Undisclosed

Private Placement

Undisclosed

Acquisition

Undisclosed

Acquisition

$93,000,000

Collaboration

Undisclosed

Licensing

$75,000,000

Private Placement

$28,000,000

Licensing

$8,000,000

Collaboration

Undisclosed

Collaboration

Undisclosed

Collaboration

Undisclosed

Acquisition

$300,000,000

Acquisition

$250,000,000

Funding & Distribution

$5,000,000

Collaboration

Undisclosed

Private Placement

$8,000,000

Distribution

Undisclosed

Distribution

Undisclosed

Private Placement

$21,000,000

Private Placement

Undisclosed

Asset Sales

$200,000,000

 

Acquisition

$130,000,000

 

Licensing

$58,000,000

 

Research Collaboration

$300,000,000

 

Acquisition

$59,000,000

 

Private Placement

$12,000,000

 

Equity Investment

Undisclosed

 

Equity Investment

Undisclosed

 

Licensing

$95,000,000

Reverse Take Over

$65,000,000

Acquisition

$500,000,000

Option to Buy Agreement

$35,000,000

Series A Financing

Undisclosed

Product Line Acquisition

Undisclosed

 
 

Contact
Us

 

Extera Partners LLC
180 Wells Avenue
Newton, MA 02459

exteramap
 
ep_logo4_white

© Extera Partners, 2024